High frequency episodic migraine and depression have high quality evidence as predictors of the transformation from episodic migraine to chronic migraine, while annual household income over $50,000 may be protective.

Of 5695 identified publications, 11 were eligible for inclusion. The pooled analysis (GRADE system) found “high” evidence for monthly headache day frequency ≥ 10 (risk ratio = 5.95), “moderate” evidence for depression (risk ratio = 1.58), monthly headache day frequency ≥ 5 (risk ratio = 3.18), and annual household income ≥ $50,000 (risk ratio = 0.65) and “very low” evidence for allodynia (risk ratio = 1.40) and medication overuse (risk ratio = 8.82) in predicting progression to chronic migraine.

An electronic search was conducted for published, prospective, cohort studies that reported risk factors for chronic migraine among people with episodic migraine. Risk of bias was assessed using the Newcastle-Ottawa Quality Assessment Scale. Quality of evidence was determined according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) guidelines. Effect estimates were retrieved and summarized using risk ratios.

An estimated 2.5–3.1% of people with episodic migraine develop chronic migraine in a year. Several risk factors are associated with an increased risk for this transformation. We conducted a systematic review and meta-analysis to provide quantitative and qualitative data on predictors of this transformation.

References

1. The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 33: 629–808.

Google Scholar

2. Mathew, NT, Reuveni, U, Perez, F. Transformed or evolutive migraine . Headache 1987 ; 27: 102 – 106 .

Google Scholar Crossref | Medline | ISI

3. Olesen, J . International Classification of Headache Disorders, Second Edition (ICHD-2): Current status and future revisions . Cephalalgia 2006 ; 26: 1409 – 1410 .

Google Scholar SAGE Journals | ISI

4. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders, 3rd edition. Cephalalgia 2018; 38: 1–211.

Google Scholar

5. Buse, DC, Manack, AN, Fanning, KM, et al. Chronic migraine prevalence, disability, and sociodemographic factors: Results from the American Migraine Prevalence and Prevention Study . Headache 2012 ; 52: 1456 – 1470 .

Google Scholar Crossref | Medline | ISI

6. Natoli, JL, Manack, A, Dean, B, et al. Global prevalence of chronic migraine: A systematic review . Cephalalgia 2010 ; 30: 599 – 609 .

Google Scholar SAGE Journals | ISI

7. Manack, AN, Buse, DC, Lipton, RB. Chronic migraine: Epidemiology and disease burden . Curr Pain Headache Rep 2011 ; 15: 70 – 78 .

Google Scholar Crossref | Medline | ISI

8. Buse, DC, Manack, A, Serrano, D, et al. Sociodemographic and comorbidity profiles of chronic migraine and episodic migraine sufferers . J Neurol Neurosurg Psychiatry 2010 ; 81: 428 – 432 .

Google Scholar Crossref | Medline | ISI

9. Bigal, ME, Lipton, RB. Obesity is a risk factor for transformed migraine but not chronic tension-type headache . Neurology 2006 ; 67: 252 – 252 .

Google Scholar Crossref | Medline | ISI

10. Scher, AI, Midgette, LA, Lipton, RB. Risk factors for headache chronification . Headache 2010 ; 48: 16 – 25 .

Google Scholar Crossref

11. Louter, MA, Bosker, JE, van Oosterhout, WP, et al. Cutaneous allodynia as a predictor of migraine chronification . Brain 2013 ; 136: 3489 – 3496 .

Google Scholar Crossref | Medline | ISI

12. Scher, AI, Stewart, WF, Buse, D, et al. Major life changes before and after the onset of chronic daily headache: A population-based study . Cephalalgia 2008 ; 28: 868 – 876 .

Google Scholar SAGE Journals | ISI

13. Bigal, ME, Lipton, RB. Modifiable risk factors for migraine progression . Headache 2010 ; 46: S144 – S146 .

Google Scholar Crossref

14. Buse DC, Greisman JD, Baigi K, et al. Migraine progression: A systematic review. Headache 2019; 59: 306–338.

Google Scholar

15. Stroup, DF, Berlin, JA, Morton, SC, et al. Meta-analysis of observational studies in epidemiology: A proposal for reporting. Meta-analysis of Observational Studies in Epidemiology (MOOSE) group . JAMA 2000 ; 283: 2008 – 2012 .

Google Scholar Crossref | Medline | ISI

16. Wells G, Shea B, O'Connell D, et al. The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa, ON: Ottawa Hospital Research Institute. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp (2011, accessed 10 Decmber 2018).

Google Scholar

17. Xiong, J, Wang, M, Zhang, Y, et al. Association of Geriatric Nutritional Risk Index with mortality in hemodialysis patients: A meta-analysis of cohort studies . Kidney Blood Press Res 2018 ; 43: 1878 – 1889 .

Google Scholar Crossref | Medline

18. Huguet, A, Hayden, JA, Stinson, J, et al. Judging the quality of evidence in reviews of prognostic factor research: Adapting the GRADE framework . Syst Rev 2013 ; 2: 71 – 71 .

Google Scholar Crossref | Medline

19. Zhang, J, Yu, KF. What’s the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes . JAMA 1998 ; 280: 1690 – 1691 .

Google Scholar Crossref | Medline | ISI

20. Ronksley, PE, Brien, SE, Turner, BJ, et al. Association of alcohol consumption with selected cardiovascular disease outcomes: A systematic review and meta-analysis . BMJ 2011 ; 342: d671 – d671 .

Google Scholar Crossref | Medline

21. Bewick, V, Cheek, L, Ball, J. Statistics review 11: Assessing risk . Crit Care 2004 ; 8: 287 – 291 .

Google Scholar Crossref | Medline

22. Seferoǧlu, M, Karli, N, Zarifoǧlu, M, et al. Factors for progression and chronification of episodic migraine: One-year face-to-face follow-up study . J Neurol Sci Turk 2012 ; 29: 1 – 10 .

Google Scholar

23. Scher, AI, Wang, SJ, Katsarava, Z, et al. Epidemiology of migraine in men: Results from the Chronic Migraine Epidemiology and Outcomes (CaMEO) Study . Cephalalgia 2019 ; 39: 296–305.

Google Scholar

24. Deeks JJ and Higgins JPT. Statistical Algorithms in Review Manager 5: on behalf of the Statistical Methods Group of The Cochrane Collaboration. 2010. http://ims.cochrane.org/ (accessed 10 December 2018).

Google Scholar

25. Bigal, ME, Serrano, D, Buse, D, et al. Acute migraine medications and evolution from episodic to chronic migraine: A longitudinal population-based study . Headache 2008 ; 48: 1157 – 1168 .

Google Scholar Crossref | Medline | ISI

26. Ashina, S, Serrano, D, Lipton, RB, et al. Depression and risk of transformation of episodic to chronic migraine . J Headache Pain 2012 ; 13: 615 – 624 .

Google Scholar Crossref | Medline | ISI

27. Lipton, RB, Serrano, D, Nicholson, RA, et al. Impact of NSAID and triptan use on developing chronic migraine: Results from the American Migraine Prevalence and Prevention (AMPP) study . Headache 2013 ; 53: 1548 – 1563 .

Google Scholar Crossref | Medline | ISI

28. Lipton, RB, Fanning, KM, Serrano, D, et al. Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine . Neurology 2015 ; 84: 688 – 695 .

Google Scholar Crossref | Medline | ISI

29. Reed, ML, Fanning, KM, Serrano, D, et al. Persistent frequent nausea is associated with progression to chronic migraine: AMPP study results . Headache 2015 ; 55: 76 – 87 .

Google Scholar Crossref | Medline

30. Martin, VT, Fanning, KM, Serrano, D, et al. Asthma is a risk factor for new onset chronic migraine: Results from the American Migraine Prevalence and Prevention study . Headache 2016 ; 56: 118 – 131 .

Google Scholar Crossref | Medline

31. Katsarava, Z, Schneeweiss, S, Kurth, T, et al. Incidence and predictors for chronicity of headache in patients with episodic migraine . Neurology 2004 ; 62: 788 – 790 .

Google Scholar Crossref | Medline | ISI

32. Ozge, A, Sasmaz, T, Bugdayci, R, et al. The prevalence of chronic and episodic migraine in children and adolescents . Eur J Neurol 2013 ; 20: 95 – 101 .

Google Scholar Crossref | Medline

33. Scher, AI, Buse, DC, Fanning, KM, et al. Comorbid pain and migraine chronicity: The Chronic Migraine Epidemiology and Outcomes Study . Neurology 2017 ; 89: 461 – 468 .

Google Scholar Crossref | Medline

34. Kroenke, K, Spitzer, RL, Williams, JB. The PHQ-9: Validity of a brief depression severity measure . J Gen Intern Med 2001 ; 16: 606 – 613 .

Google Scholar Crossref | Medline | ISI

35. Deeks JJ, Higgins JP and Altman DG. Chapter 9. Analysing data and undertaking meta-analyses. In: Higgins JP and Green S (eds) Cochrane Handbook for Systematic Reviews of Interventions: Cochrane Book Series, pp. 243–296. The Cochrane Library (www.thecochranelibrary.com), vision 5.1.0, (updated March 2011).

Google Scholar

36. Probyn K, Bowers H, Caldwell F, et al. Prognostic factors for chronic headache: A systematic review. Neurology 2017; 89: 291–301.

Google Scholar

37. Torres-Ferrus, M, Quintana, M, Fernandez-Morales, J, et al. When does chronic migraine strike? A clinical comparison of migraine according to the headache days suffered per month . Cephalalgia 2017 ; 37: 104 – 113 .

Google Scholar SAGE Journals | ISI

38. Ophoff, RA, Terwindt, GM, Vergouwe, MN, et al. Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4 . Cell 1996 ; 87: 543 – 552 .

Google Scholar Crossref | Medline | ISI

39. Ulrich, V, Gervil, M, Kyvik, KO, et al. Evidence of a genetic factor in migraine with aura: A population-based Danish twin study . Ann Neurol 1999 ; 45: 242 – 246 .

Google Scholar Crossref | Medline | ISI

40. Stewart, WF, Staffa, J, Lipton, RB, et al. Familial risk of migraine: A population-based study . Ann Neurol 1997 ; 41: 166 – 172 .

Google Scholar Crossref | Medline | ISI

41. Serrano, D, Lipton, RB, Scher, AI, et al. Fluctuations in episodic and chronic migraine status over the course of 1 year: Implications for diagnosis, treatment and clinical trial design . J Headache Pain 2017 ; 18: 101 – 101 .

Google Scholar Crossref | Medline

42. Houle, TT, Turner, DP, Smitherman, TA, et al. Influence of random measurement error on estimated rates of headache chronification and remission . Headache 2013 ; 53: 920 – 929 .

Google Scholar Crossref | Medline | ISI

43. Turner, DP, Smitherman, TA, Penzien, DB, et al. Rethinking headache chronification . Headache 2013 ; 53: 901 – 907 .

Google Scholar Crossref | Medline

44. Burstein, R, Jakubowski, M, Garcia-Nicas, E, et al. Thalamic sensitization transforms localized pain into widespread allodynia . Ann Neurol 2010 ; 68: 81 – 91 .

Google Scholar Crossref | Medline | ISI

45. Lipton, RB, Bigal, ME, Ashina, S, et al. Cutaneous allodynia in the migraine population . Ann Neurol 2008 ; 63: 148 – 158 .

Google Scholar Crossref | Medline | ISI

46. Ashina, S, Buse, D, Bigal, M, et al. Cutaneous allodynia – a predictor of migraine chronification: A longitudinal population-based study . Cephalalgia 2009 ; 29: 58 – 59 .

Google Scholar Medline

47. De Felice, M, Ossipov, MH, Wang, R, et al. Triptan-induced latent sensitization: A possible basis for medication overuse headache . Ann Neurol 2010 ; 67: 325 – 337 .

Google Scholar Medline | ISI

48. Stewart, WF, Lipton, RB, Celentano, DD, et al. Prevalence of migraine headache in the United States. Relation to age, income, race, and other sociodemographic factors . JAMA 1992 ; 267: 64 – 69 .

Google Scholar Crossref | Medline | ISI

49. Hagen, K, Vatten, L, Stovner, LJ, et al. Low socio-economic status is associated with increased risk of frequent headache: A prospective study of 22,718 adults in Norway . Cephalalgia 2002 ; 22: 672 – 679 .

Google Scholar SAGE Journals | ISI

50. Ahern, J, Galea, S. Social context and depression after a disaster: The role of income inequality . J Epidemiol Commun Health 2006 ; 60: 766 – 770 .

Google Scholar Crossref | Medline | ISI

51. Burns, JK, Tomita, A, Lund, C. Income inequality widens the existing income-related disparity in depression risk in post-apartheid South Africa: Evidence from a nationally representative panel study . Health Place 2017 ; 45: 10 – 16 .

Google Scholar Crossref | Medline

52. Sauro, KM, Rose, MS, Becker, WJ, et al. HIT-6 and MIDAS as measures of headache disability in a headache referral population . Headache 2010 ; 50: 383 – 395 .

Google Scholar Crossref | Medline | ISI

53. Buse, D, Manack, A, Serrano, D, et al. Headache impact of chronic and episodic migraine: Results from the American Migraine Prevalence and Prevention study . Headache 2012 ; 52: 3 – 17 .

Google Scholar Crossref | Medline | ISI

54. Raggi, A, Giovannetti, AM, Leonardi, M, et al. Predictors of 12-months relapse after withdrawal treatment in hospitalized patients with chronic migraine associated with medication overuse: A longitudinal observational study . Headache 2017 ; 57: 60 – 70 .

Google Scholar Crossref | Medline

55. Higgins JPT and Green S. Cochrane handbook for systematic reviews of interventions Version 5.1.0: The Cochrane Collaboration, www.cochrane-handbook.org (March 2011, accessed xxxx).

Google Scholar

56. Hill, AB . The environment and disease: Association or causation? Proc R Soc Med 1965 ; 58: 295 – 300 .

Google Scholar SAGE Journals

57. Raggi, A, Grazzi, L, Ayadi, R, et al. Clinical and psychosocial features of frequent relapsers (FR) among patients with chronic migraine and medication overuse . Neurol Sci 2017 ; 38: 169 – 171 .

Google Scholar Crossref | Medline